Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom

Cancer

Volumn 96, Issue 1, 2002, Pages 14-20

  Scott, David R ^a   Hagmar, Bjorn ^b   Maddox, Peter ^c   Hjerpe, Anders ^d   Dillner, Joakim ^e   Cuzick, Jack ^c   Sherman, Mark E ^f   Stoler, Mark H ^g   Kurman, Robert J ^h   Kiviat, Nancy B ⁱ   Manos, M Michele ^j   Schiffman, Mark ^f  

^a KAISER PERMANENTE   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j NOVARTIS PHARMA AG   (Switzerland)

more..

Author keywords

Atypical squamous cells of undetermined significance (ASCUS); Cervical cytology; Human papillomavirus (HPV); Papanicolaou tests; Reproducibility; The Bethesda System

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CALIBRATION; CYTOPATHOLOGY; DISEASE CLASSIFICATION; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PRIORITY JOURNAL; SCANDINAVIA; STANDARDIZATION; STATISTICAL ANALYSIS; UNITED KINGDOM; UNITED STATES; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADOLESCENT; ADULT; AGED; CALIBRATION; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; GREAT BRITAIN; HUMANS; INTERNATIONAL COOPERATION; MIDDLE AGED; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; RETROSPECTIVE STUDIES; SCANDINAVIA; TUMOR VIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037170129     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10317     Document Type: Article

References (28)

1. IARC monograph on the evaluation of carcinogenic risks to humans
2. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
3. The ASCUS-LSIL triage study (ALTS): Design, methods, and characteristics of trial participants
4. Can papilloma virus testing be used to improve cervical cancer screening?
5. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: Summary and conclusions
6. A population-based five-year follow-up study of cervical human papillomavirus infection
7. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia
8. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
9. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papnaicolaou results
10. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1518 women
11. Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytology study, cervicography, and human papillomavirus detection
12. Human papillomavirus testing in women with mild cytologic atypia
13. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
14. Interim guidelines for management of abnormal Cervical cytology. The 1992 National Cancer Institute Workshop
15. Review of the Bethesda System Atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance
16. Towards objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types
17. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
18. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
19. Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear
20. Dysplasia: A real concept or a misnomer?
21. A follow-up study of patients with cervical dysplasia
22. Persistence of type-specific human papillomavirus infection among cytologically normal women in Portland, Oregon
23. The measurement of observer agreement for categorical and data
24. Inter-observer reproducibility of cervical cytologic and histologic diagnoses: Realistic estimates from the ASCUS-LSIL Triage Study (ALTS)
25. HPV testing as a triage strategy for women with cytologic evidence of low grade squamous intraepithelial lesions: Early results from a randomized trial on the clinical management of ASCUS and LSIL cytologic abnormalities
26. A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia